Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development.
Saved in:
| Title: | Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development. |
|---|---|
| Authors: | Overgaard RV; Quantitative Clinical Pharmacology, Novo Nordisk A/S Søborg, Denmark., Ingwersen SH; Quantitative Clinical Pharmacology, Novo Nordisk A/S Søborg, Denmark., Tornøe CW; Quantitative Clinical Pharmacology, Novo Nordisk A/S Søborg, Denmark. |
| Source: | CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2015 Oct; Vol. 4 (10), pp. 565-75. Date of Electronic Publication: 2015 Sep 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2163-8306 (Print) Linking ISSN: 21638306 NLM ISO Abbreviation: CPT Pharmacometrics Syst Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2163-8306 |
|---|---|
| DOI: | 10.1002/psp4.12015 |
